ART1 (Gene)

Organism:

Homo sapiens

Synonyms:ADP-ribosyltransferase 1, ART1, ART2, ARTC1, CD296, ENTREZ:417, HGNC:723, MIM:601625, NM_004314, NP_004305, RT6, XM_011520114, XM_017017763, XP_011518416, XP_016873252

Omim:OMIM:601625

Id:ENSG00000129744

Hgnc:HGNC:723

Entrez:417

Ensembl:ENSG00000129744

Description:ADP-ribosyltransferase 1

ADP-ribosyltransferase catalyzes the ADP-ribosylation of arginine residues in proteins. Mono-ADP-ribosylation is a posttranslational modification of proteins that is interfered with by a variety of bacterial toxins including cholera, pertussis, and heat-labile enterotoxins of E. coli. The amino acid sequence consists of predominantly hydrophobic N- and C-terminal regions, which is characteristic of glycosylphosphatidylinositol (GPI)-anchored proteins. This gene was previously designated ART2. [provided by RefSeq, Jul 2008]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ART1's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ART1.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ART1.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ART1.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ART1.

Results found

Linked to

	Label	Description
	GSE150540 dipyridamole DPM HUVEC-C 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE109285 5 V 2 GLUCAGON MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE213845 EZH2 inhibition 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE92965 0 V 1 TAMOXIFEN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE226114,GSE226116 2 V 0 DOXORUBICIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE169571 5 V 4 DEXAMETHASONE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE252857 1 V 0 PREDNISONE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE212231 GSE218491 SHP2 inhibition 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195559 NOTCH1 knockout endothelial cell cardiac muscle cell stem cell 6 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	T56-Vastus-Lateralis Consensus Gene Set (Entity type)	A Gene Set from MoTrPAC

GSE150540 dipyridamole DPM HUVEC-C 1 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE109285 5 V 2 GLUCAGON MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE213845 EZH2 inhibition 2 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE92965 0 V 1 TAMOXIFEN MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE226114,GSE226116 2 V 0 DOXORUBICIN MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE169571 5 V 4 DEXAMETHASONE MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE252857 1 V 0 PREDNISONE MOUSE DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE212231 GSE218491 SHP2 inhibition 3 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE195559 NOTCH1 knockout endothelial cell cardiac muscle cell stem cell 6 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

T56-Vastus-Lateralis Consensus

Gene Set (Entity type)

A Gene Set from MoTrPAC

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.